Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Endostar continuous pump + ICI + chemotherapy in advanced lung squamous cell carcinoma
NCT05782764Phase 4Unknown
- Sponsor
- Xuzhou Medical University
- Start
- Jun 2023
- Primary completion
- May 2025
- Modality
- rProtein (Recombinant Protein), Biologic
- Countries
- 1
01
Overview
A Phase 4 trial of endostar in squamous cell carcinoma of the lung (LSCC), sponsored by Xuzhou Medical University. Status: unknown.
02
Drugs
endostar
03
Conditions
squamous cell carcinoma of the lung (LSCC)
Beyond the preview
Go deeper on NCT05782764.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT05782764.